Axepta
Atomoxetine tablets for attention deficit hyperactivity disorder. It is a non-stimulant, which makes it an option for those who cannot tolerate stimulant medicines.
All strengths and pack prices
| Strength | Pack | Price | Per unit |
|---|---|---|---|
| 10mg | 10 tablets | $72.00 | $7.20 |
| 10mg | 20 tablets | $81.00 | $4.05 |
| 10mg | 30 tablets | $90.00 | $3.00 |
| 10mg | 60 tablets | $99.00 | $1.65 |
| 10mg | 90 tablets | $108.00 | $1.20 |
| 10mg | 120 tablets | $125.00 | $1.04 |
| 10mg | 180 tablets | $179.00 | $0.99 |
| 10mg | 270 tablets | $259.00 | $0.96 |
| 10mg | 360 tablets | $322.00 | $0.89 |
| 18mg | 10 tablets | $68.00 | $6.80 |
| 18mg | 20 tablets | $75.00 | $3.75 |
| 18mg | 30 tablets | $83.00 | $2.77 |
| 18mg | 60 tablets | $105.00 | $1.75 |
| 18mg | 90 tablets | $150.00 | $1.67 |
| 18mg | 120 tablets | $195.00 | $1.63 |
| 18mg | 180 tablets | $270.00 | $1.50 |
| 18mg | 270 tablets | $374.00 | $1.39 |
| 18mg | 360 tablets | $472.00 | $1.31 |
| 25mg | 10 tablets | $76.00 | $7.60 |
| 25mg | 20 tablets | $84.00 | $4.20 |
| 25mg | 30 tablets | $92.00 | $3.07 |
| 25mg | 60 tablets | $137.00 | $2.28 |
| 25mg | 90 tablets | $198.00 | $2.20 |
| 25mg | 120 tablets | $244.00 | $2.03 |
| 25mg | 180 tablets | $304.00 | $1.69 |
| 25mg | 270 tablets | $411.00 | $1.52 |
| 25mg | 360 tablets | $456.00 | $1.27 |
| 40mg | 10 tablets | $77.00 | $7.70 |
| 40mg | 20 tablets | $90.00 | $4.50 |
| 40mg | 30 tablets | $141.00 | $4.70 |
| 40mg | 60 tablets | $256.00 | $4.27 |
| 40mg | 90 tablets | $333.00 | $3.70 |
| 40mg | 120 tablets | $384.00 | $3.20 |
| 40mg | 180 tablets | $500.00 | $2.78 |
| 40mg | 270 tablets | $576.00 | $2.13 |
| 40mg | 360 tablets | $640.00 | $1.78 |
- Categories
- Mental Health · ADHD & Focus
- Active ingredient
- Atomoxetine
- Route
- Oral use
- Form
- Tablet
- Strengths
- 10mg · 18mg · 25mg · 40mg
Prescription and consultation requirements for Axepta vary by destination and are determined by the fulfilment partner.
Axepta details
- Alternative names
- atomoxetine
- Therapeutic class
- Selective Norepinephrine Reuptake Inhibitor (SNRI)
- Pharmacological class
- Non-Stimulant ADHD Agent
- Known off-label uses
- narcolepsy
- Contraindications
- narrow-angle glaucoma; pheochromocytoma; MAO inhibitor therapy
- Minor side effects
- nausea; decreased appetite; somnolence
- Moderate side effects
- dry mouth; erectile dysfunction; insomnia
- Dosage forms
- Tablet
- Administration route
- Oral use
- Manufacturer
- Torrent Pharmaceuticals Ltd
- Onset time
- 2–4 weeks
- Duration
- 12–24 hours
- Storage instructions
- Store below 25°C.
- Drug interactions
- MAO Inhibitors; Fluoxetine; Paroxetine
- Age restrictions
- Approved for children over six years, adolescents, and adults.
- Pregnancy and breastfeeding
- Pregnancy: Use if clinically needed. Breastfeeding: Consult a doctor.
Serious side effects
suicidal ideation, requires immediate medical attention; severe hepatotoxicity, requires immediate medical attention
Patient summary
Atomoxetine tablets for attention deficit hyperactivity disorder. It is a non-stimulant, which makes it an option for those who cannot tolerate stimulant medicines.
Mechanism of action
Selectively inhibits the presynaptic norepinephrine transporter, elevating extracellular transmitter levels in the prefrontal cortex.